Agomelatine as augmentation therapy with second‐generation antipsychotics for negative symptoms of schizophrenia: An open‐label randomised clinical trial and electroencephalogram‐derived model for treatment response prediction

Wanyan Zhou, Fei Liang, Nizhe Chen, Yao Zhang, Xiaoxiao Wang, Xin Li, Daofeng Lu, Fang Guo, Yuan Yao, Jiayu Zhu, Chengjia Shen, Chongze Wang, Peiyun Zhang, Lilan Zhao, Ying Wang, Jinyu Han, Wei Li, Haisu Wu, Peijuan Wang, Qi Yan, Ping Zhang, Qinyu Lv, Zhenghui Yi

Open source

DOI: 10.1002/gps3.70045
Published: 2026-09-16
Container: General Psychiatry
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/gps3.70045,
  title = {Agomelatine as augmentation therapy with second‐generation antipsychotics for negative symptoms of schizophrenia: An open‐label randomised clinical trial and electroencephalogram‐derived model for treatment response prediction},
  author = {Wanyan Zhou and Fei Liang and Nizhe Chen and Yao Zhang and Xiaoxiao Wang and Xin Li and Daofeng Lu and Fang Guo and Yuan Yao and Jiayu Zhu and Chengjia Shen and Chongze Wang and Peiyun Zhang and Lilan Zhao and Ying Wang and Jinyu Han and Wei Li and Haisu Wu and Peijuan Wang and Qi Yan and Ping Zhang and Qinyu Lv and Zhenghui Yi},
  year = {2026},
  journal = {General Psychiatry},
  doi = {10.1002/gps3.70045},
  url = {https://doi.org/10.1002/gps3.70045}
}

RIS

TY  - JOUR
TI  - Agomelatine as augmentation therapy with second‐generation antipsychotics for negative symptoms of schizophrenia: An open‐label randomised clinical trial and electroencephalogram‐derived model for treatment response prediction
AU  - Wanyan Zhou
AU  - Fei Liang
AU  - Nizhe Chen
AU  - Yao Zhang
AU  - Xiaoxiao Wang
AU  - Xin Li
AU  - Daofeng Lu
AU  - Fang Guo
AU  - Yuan Yao
AU  - Jiayu Zhu
AU  - Chengjia Shen
AU  - Chongze Wang
AU  - Peiyun Zhang
AU  - Lilan Zhao
AU  - Ying Wang
AU  - Jinyu Han
AU  - Wei Li
AU  - Haisu Wu
AU  - Peijuan Wang
AU  - Qi Yan
AU  - Ping Zhang
AU  - Qinyu Lv
AU  - Zhenghui Yi
PY  - 2026
JO  - General Psychiatry
DO  - 10.1002/gps3.70045
UR  - https://doi.org/10.1002/gps3.70045
ER  -

APA

Zhou, W., Liang, F., Chen, N., Zhang, Y., Wang, X., Li, X., Lu, D., Guo, F., Yao, Y., Zhu, J., Shen, C., Wang, C., Zhang, P., Zhao, L., Wang, Y., Han, J., Li, W., Wu, H., Wang, P., Yan, Q., Zhang, P., Lv, Q., & Yi, Z. (2026). Agomelatine as augmentation therapy with second‐generation antipsychotics for negative symptoms of schizophrenia: An open‐label randomised clinical trial and electroencephalogram‐derived model for treatment response prediction. General Psychiatry. https://doi.org/10.1002/gps3.70045

Source records

crossref · retrieved 2026-09-25T03:12:13.308Z